Reply to Abenavoli et al. Comment on “Clayton-Chubb et al. Understanding NAFLD: From Case Identification to Interventions, Outcomes, and Future Perspectives. Nutrients 2023, 15, 687”-Reference-Cited by-同舟云学术

Reply to Abenavoli et al. Comment on “Clayton-Chubb et al. Understanding NAFLD: From Case Identification to Interventions, Outcomes, and Future Perspectives. Nutrients 2023, 15, 687”

Published:2023-06-27 Issue:13 Volume:15 Page:2908
ISSN:2072-6643
Container-title:Nutrients
language:en
Short-container-title:Nutrients

Author:

Clayton-Chubb Daniel¹²³^ORCID,Kemp William¹²^ORCID,Majeed Ammar¹²,Lubel John S.¹²,Hodge Alex³⁴,Roberts Stuart K.¹²

Affiliation:

1. Department of Gastroenterology, The Alfred Hospital, Melbourne, VIC 3004, Australia

2. Central Clinical School, Monash University, Melbourne, VIC 3004, Australia

3. Department of Gastroenterology, Eastern Health, Box Hill, VIC 3128, Australia

4. Eastern Health Clinical School, Monash University, Box Hill, VIC 3128, Australia

Abstract

Thank you for your interesting comment [...]

Publisher

MDPI AG

Subject

Food Science,Nutrition and Dietetics

Link

https://www.mdpi.com/2072-6643/15/13/2908/pdf

Reference5 articles.

1. Abenavoli, L., La Torre, G., and Milic, N. (2023). Comment on Clayton-Chubb et al. Understanding NAFLD: From Case Identification to Interventions, Outcomes, and Future Perspectives. Nutrients 2023, 15, 687. Nutrients, 15.

2. Clayton-Chubb, D., Kemp, W., Majeed, A., Lubel, J.S., Hodge, A., and Roberts, S.K. (2023). Understanding NAFLD: From Case Identification to Interventions, Outcomes, and Future Perspectives. Nutrients, 15.

3. Liver Disease in Patients on Total Parenteral Nutrition;Mitra;Clin. Liver Dis.,2017

4. Regression of Liver Steatosis Following Phosphatidylcholine Administration: A Review of Molecular and Metabolic Pathways Involved;Osipova;Front. Pharmacol.,2022

5. Dietary phosphatidylcholine and risk of all-cause and cardiovascular-specific mortality among US women and men;Zheng;Am. J. Clin. Nutr.,2016